BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23187123)

  • 1. A calcium channel mutant mouse model of hypokalemic periodic paralysis.
    Wu F; Mi W; Hernández-Ochoa EO; Burns DK; Fu Y; Gray HF; Struyk AF; Schneider MF; Cannon SC
    J Clin Invest; 2012 Dec; 122(12):4580-91. PubMed ID: 23187123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voltage-dependent Ca
    DiFranco M; Cannon SC
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C478-C485. PubMed ID: 35759432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sodium channel knockin mutant (NaV1.4-R669H) mouse model of hypokalemic periodic paralysis.
    Wu F; Mi W; Burns DK; Fu Y; Gray HF; Struyk AF; Cannon SC
    J Clin Invest; 2011 Oct; 121(10):4082-94. PubMed ID: 21881211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis.
    Wu F; Mi W; Cannon SC
    Brain; 2013 Dec; 136(Pt 12):3766-74. PubMed ID: 24142145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K+ current.
    Ruff RL
    Neurology; 1999 Oct; 53(7):1556-63. PubMed ID: 10534267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation.
    Struyk AF; Scoggan KA; Bulman DE; Cannon SC
    J Neurosci; 2000 Dec; 20(23):8610-7. PubMed ID: 11102465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupted coupling of gating charge displacement to Na+ current activation for DIIS4 mutations in hypokalemic periodic paralysis.
    Mi W; Rybalchenko V; Cannon SC
    J Gen Physiol; 2014 Aug; 144(2):137-45. PubMed ID: 25024265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gating pore currents occur in CaV1.1 domain III mutants associated with HypoPP.
    Wu F; Quinonez M; Cannon SC
    J Gen Physiol; 2021 Nov; 153(11):. PubMed ID: 34463712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current.
    Jurkat-Rott K; Mitrovic N; Hang C; Kouzmekine A; Iaizzo P; Herzog J; Lerche H; Nicole S; Vale-Santos J; Chauveau D; Fontaine B; Lehmann-Horn F
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9549-54. PubMed ID: 10944223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stac3 enhances expression of human Ca
    Wu F; Quinonez M; DiFranco M; Cannon SC
    J Gen Physiol; 2018 Mar; 150(3):475-489. PubMed ID: 29386226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gating pore currents in DIIS4 mutations of NaV1.4 associated with periodic paralysis: saturation of ion flux and implications for disease pathogenesis.
    Struyk AF; Markin VS; Francis D; Cannon SC
    J Gen Physiol; 2008 Oct; 132(4):447-64. PubMed ID: 18824591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Na+ channel mutation linked to hypokalemic periodic paralysis exposes a proton-selective gating pore.
    Struyk AF; Cannon SC
    J Gen Physiol; 2007 Jul; 130(1):11-20. PubMed ID: 17591984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations associated with hypokalemic periodic paralysis: from hotspot regions to complete analysis of CACNA1S and SCN4A genes.
    Brugnoni R; Canioni E; Filosto M; Pini A; Tonin P; Rossi T; Canavese C; Eoli M; Siciliano G; Lauria G; Mantegazza R; Maggi L
    Neurogenetics; 2022 Jan; 23(1):19-25. PubMed ID: 34608571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient compartment-like syndrome and normokalaemic periodic paralysis due to a Ca(v)1.1 mutation.
    Fan C; Lehmann-Horn F; Weber MA; Bednarz M; Groome JR; Jonsson MK; Jurkat-Rott K
    Brain; 2013 Dec; 136(Pt 12):3775-86. PubMed ID: 24240197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated resting H
    Fuster C; Perrot J; Berthier C; Jacquemond V; Allard B
    J Physiol; 2017 Oct; 595(20):6417-6428. PubMed ID: 28857175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gating of the HypoPP-1 mutations: I. Mutant-specific effects and cooperativity.
    Kuzmenkin A; Hang C; Kuzmenkina E; Jurkat-Rott K
    Pflugers Arch; 2007 Jun; 454(3):495-505. PubMed ID: 17333249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permanent muscle weakness in hypokalemic periodic paralysis.
    Holm-Yildiz S; Witting N; Dahlqvist J; de Stricker Borch J; Solheim T; Fornander F; Eisum AS; Duno M; Soerensen T; Vissing J
    Neurology; 2020 Jul; 95(4):e342-e352. PubMed ID: 32580975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retigabine suppresses loss of force in mouse models of hypokalaemic periodic paralysis.
    Quiñonez M; DiFranco M; Wu F; Cannon SC
    Brain; 2023 Apr; 146(4):1554-1560. PubMed ID: 36718088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voltage-sensor mutations in channelopathies of skeletal muscle.
    Cannon SC
    J Physiol; 2010 Jun; 588(Pt 11):1887-95. PubMed ID: 20156847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bumetanide prevents transient decreases in muscle force in murine hypokalemic periodic paralysis.
    Wu F; Mi W; Cannon SC
    Neurology; 2013 Mar; 80(12):1110-6. PubMed ID: 23427324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.